nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CA7—colon cancer	0.814	1	CbGaD
Diclofenamide—CA14—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0166	0.125	CbGpPWpGaD
Diclofenamide—CA6—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0162	0.122	CbGpPWpGaD
Diclofenamide—CA5A—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0162	0.122	CbGpPWpGaD
Diclofenamide—CA5B—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0151	0.113	CbGpPWpGaD
Diclofenamide—CA12—Reversible hydration of carbon dioxide—CA7—colon cancer	0.014	0.105	CbGpPWpGaD
Diclofenamide—CA4—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0112	0.0838	CbGpPWpGaD
Diclofenamide—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0107	0.0804	CbGpPWpGaD
Diclofenamide—CA1—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0103	0.0771	CbGpPWpGaD
Diclofenamide—CA9—Reversible hydration of carbon dioxide—CA7—colon cancer	0.00904	0.0677	CbGpPWpGaD
Diclofenamide—Trichlormethiazide—CA7—colon cancer	0.00333	1	CrCbGaD
Diclofenamide—CA9—gall bladder—colon cancer	0.00257	0.12	CbGeAlD
Diclofenamide—Hepatic insufficiency—Methotrexate—colon cancer	0.00224	0.0798	CcSEcCtD
Diclofenamide—Electrolyte imbalance—Irinotecan—colon cancer	0.00166	0.0593	CcSEcCtD
Diclofenamide—CA7—renal system—colon cancer	0.0014	0.0658	CbGeAlD
Diclofenamide—CA5A—liver—colon cancer	0.00129	0.0605	CbGeAlD
Diclofenamide—CA7—digestive system—colon cancer	0.00115	0.054	CbGeAlD
Diclofenamide—CA9—digestive system—colon cancer	0.00101	0.0474	CbGeAlD
Diclofenamide—CA2—gall bladder—colon cancer	0.000976	0.0458	CbGeAlD
Diclofenamide—CA12—renal system—colon cancer	0.000912	0.0428	CbGeAlD
Diclofenamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—colon cancer	0.000829	0.00621	CbGpPWpGaD
Diclofenamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—colon cancer	0.000785	0.00589	CbGpPWpGaD
Diclofenamide—Hyperuricaemia—Vincristine—colon cancer	0.000769	0.0274	CcSEcCtD
Diclofenamide—CA12—digestive system—colon cancer	0.000748	0.0351	CbGeAlD
Diclofenamide—Blood uric acid increased—Vincristine—colon cancer	0.000727	0.0259	CcSEcCtD
Diclofenamide—CA1—renal system—colon cancer	0.000722	0.0339	CbGeAlD
Diclofenamide—CA14—liver—colon cancer	0.000715	0.0335	CbGeAlD
Diclofenamide—CA2—embryo—colon cancer	0.000619	0.029	CbGeAlD
Diclofenamide—CA1—lymphoid tissue—colon cancer	0.0006	0.0281	CbGeAlD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000593	0.00444	CbGpPWpGaD
Diclofenamide—CA1—digestive system—colon cancer	0.000593	0.0278	CbGeAlD
Diclofenamide—CA5B—vagina—colon cancer	0.000593	0.0278	CbGeAlD
Diclofenamide—Hepatic failure—Vincristine—colon cancer	0.000577	0.0206	CcSEcCtD
Diclofenamide—CA4—renal system—colon cancer	0.000565	0.0265	CbGeAlD
Diclofenamide—Eruption—Methotrexate—colon cancer	0.000563	0.0201	CcSEcCtD
Diclofenamide—CA1—bone marrow—colon cancer	0.000546	0.0256	CbGeAlD
Diclofenamide—Disorientation—Fluorouracil—colon cancer	0.00054	0.0193	CcSEcCtD
Diclofenamide—CA2—epithelium—colon cancer	0.000505	0.0237	CbGeAlD
Diclofenamide—Ataxia—Vincristine—colon cancer	0.000487	0.0174	CcSEcCtD
Diclofenamide—CA2—smooth muscle tissue—colon cancer	0.000486	0.0228	CbGeAlD
Diclofenamide—CA2—renal system—colon cancer	0.000468	0.022	CbGeAlD
Diclofenamide—CA4—digestive system—colon cancer	0.000463	0.0217	CbGeAlD
Diclofenamide—Hypokalaemia—Irinotecan—colon cancer	0.000459	0.0164	CcSEcCtD
Diclofenamide—Ataxia—Fluorouracil—colon cancer	0.000454	0.0162	CcSEcCtD
Diclofenamide—CA1—liver—colon cancer	0.000441	0.0207	CbGeAlD
Diclofenamide—CA4—bone marrow—colon cancer	0.000427	0.02	CbGeAlD
Diclofenamide—Weight decreased—Vincristine—colon cancer	0.000405	0.0144	CcSEcCtD
Diclofenamide—Weight decreased—Irinotecan—colon cancer	0.000395	0.0141	CcSEcCtD
Diclofenamide—CA2—lymphoid tissue—colon cancer	0.000389	0.0182	CbGeAlD
Diclofenamide—CA2—digestive system—colon cancer	0.000384	0.018	CbGeAlD
Diclofenamide—CA5B—lymph node—colon cancer	0.000383	0.018	CbGeAlD
Diclofenamide—Hepatic failure—Capecitabine—colon cancer	0.000376	0.0134	CcSEcCtD
Diclofenamide—Hyperuricaemia—Methotrexate—colon cancer	0.000373	0.0133	CcSEcCtD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.00037	0.00277	CbGpPWpGaD
Diclofenamide—CA9—Cellular response to hypoxia—EP300—colon cancer	0.000366	0.00274	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	0.000357	0.00267	CbGpPWpGaD
Diclofenamide—CA2—bone marrow—colon cancer	0.000354	0.0166	CbGeAlD
Diclofenamide—Blood uric acid increased—Methotrexate—colon cancer	0.000353	0.0126	CcSEcCtD
Diclofenamide—Agranulocytosis—Fluorouracil—colon cancer	0.000348	0.0124	CcSEcCtD
Diclofenamide—CA9—Cellular response to hypoxia—VEGFA—colon cancer	0.000347	0.0026	CbGpPWpGaD
Diclofenamide—CA2—vagina—colon cancer	0.000339	0.0159	CbGeAlD
Diclofenamide—CA1—lymph node—colon cancer	0.000338	0.0159	CbGeAlD
Diclofenamide—CA14—Metabolism—CA7—colon cancer	0.000338	0.00253	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CA7—colon cancer	0.00033	0.00247	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CA7—colon cancer	0.00033	0.00247	CbGpPWpGaD
Diclofenamide—CYP2C9—digestive system—colon cancer	0.000325	0.0152	CbGeAlD
Diclofenamide—Ataxia—Capecitabine—colon cancer	0.000318	0.0113	CcSEcCtD
Diclofenamide—CA5B—Metabolism—CA7—colon cancer	0.000308	0.00231	CbGpPWpGaD
Diclofenamide—Hypokalaemia—Capecitabine—colon cancer	0.000307	0.011	CcSEcCtD
Diclofenamide—CA2—liver—colon cancer	0.000286	0.0134	CbGeAlD
Diclofenamide—CA12—Metabolism—CA7—colon cancer	0.000285	0.00214	CbGpPWpGaD
Diclofenamide—Hepatic failure—Methotrexate—colon cancer	0.00028	0.00998	CcSEcCtD
Diclofenamide—Leukopenia—Vincristine—colon cancer	0.000279	0.00996	CcSEcCtD
Diclofenamide—Leukopenia—Irinotecan—colon cancer	0.000272	0.0097	CcSEcCtD
Diclofenamide—CA4—lymph node—colon cancer	0.000265	0.0124	CbGeAlD
Diclofenamide—Weight decreased—Capecitabine—colon cancer	0.000264	0.00942	CcSEcCtD
Diclofenamide—Leukopenia—Fluorouracil—colon cancer	0.000261	0.00929	CcSEcCtD
Diclofenamide—Confusional state—Irinotecan—colon cancer	0.00025	0.00892	CcSEcCtD
Diclofenamide—Thrombocytopenia—Vincristine—colon cancer	0.000249	0.00889	CcSEcCtD
Diclofenamide—Agranulocytosis—Capecitabine—colon cancer	0.000243	0.00866	CcSEcCtD
Diclofenamide—Thrombocytopenia—Irinotecan—colon cancer	0.000243	0.00866	CcSEcCtD
Diclofenamide—Anorexia—Vincristine—colon cancer	0.000243	0.00866	CcSEcCtD
Diclofenamide—CYP2C9—liver—colon cancer	0.000242	0.0114	CbGeAlD
Diclofenamide—Confusional state—Fluorouracil—colon cancer	0.000239	0.00854	CcSEcCtD
Diclofenamide—Anorexia—Irinotecan—colon cancer	0.000236	0.00843	CcSEcCtD
Diclofenamide—Ataxia—Methotrexate—colon cancer	0.000236	0.00843	CcSEcCtD
Diclofenamide—Thrombocytopenia—Fluorouracil—colon cancer	0.000233	0.00829	CcSEcCtD
Diclofenamide—Paraesthesia—Vincristine—colon cancer	0.000229	0.00815	CcSEcCtD
Diclofenamide—CA4—Metabolism—CA7—colon cancer	0.000227	0.0017	CbGpPWpGaD
Diclofenamide—Anorexia—Fluorouracil—colon cancer	0.000226	0.00807	CcSEcCtD
Diclofenamide—Paraesthesia—Irinotecan—colon cancer	0.000223	0.00794	CcSEcCtD
Diclofenamide—Decreased appetite—Vincristine—colon cancer	0.000221	0.00789	CcSEcCtD
Diclofenamide—Somnolence—Irinotecan—colon cancer	0.00022	0.00786	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Vincristine—colon cancer	0.00022	0.00784	CcSEcCtD
Diclofenamide—Fatigue—Vincristine—colon cancer	0.00022	0.00783	CcSEcCtD
Diclofenamide—CA2—lymph node—colon cancer	0.000219	0.0103	CbGeAlD
Diclofenamide—Dyspepsia—Irinotecan—colon cancer	0.000218	0.00778	CcSEcCtD
Diclofenamide—CA2—Metabolism—CA7—colon cancer	0.000218	0.00163	CbGpPWpGaD
Diclofenamide—Tinnitus—Capecitabine—colon cancer	0.000218	0.00777	CcSEcCtD
Diclofenamide—Constipation—Vincristine—colon cancer	0.000218	0.00777	CcSEcCtD
Diclofenamide—Decreased appetite—Irinotecan—colon cancer	0.000216	0.00769	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Irinotecan—colon cancer	0.000214	0.00763	CcSEcCtD
Diclofenamide—Fatigue—Irinotecan—colon cancer	0.000214	0.00762	CcSEcCtD
Diclofenamide—Paraesthesia—Fluorouracil—colon cancer	0.000213	0.00761	CcSEcCtD
Diclofenamide—Constipation—Irinotecan—colon cancer	0.000212	0.00756	CcSEcCtD
Diclofenamide—Somnolence—Fluorouracil—colon cancer	0.000211	0.00753	CcSEcCtD
Diclofenamide—Dyspepsia—Fluorouracil—colon cancer	0.000209	0.00746	CcSEcCtD
Diclofenamide—CA1—Metabolism—CA7—colon cancer	0.000209	0.00157	CbGpPWpGaD
Diclofenamide—Decreased appetite—Fluorouracil—colon cancer	0.000206	0.00736	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000205	0.00731	CcSEcCtD
Diclofenamide—CA14—Metabolism—ODC1—colon cancer	0.000205	0.00154	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CHST5—colon cancer	0.000205	0.00154	CbGpPWpGaD
Diclofenamide—Feeling abnormal—Irinotecan—colon cancer	0.000204	0.00729	CcSEcCtD
Diclofenamide—Body temperature increased—Vincristine—colon cancer	0.000201	0.00718	CcSEcCtD
Diclofenamide—CA5A—Metabolism—ODC1—colon cancer	0.0002	0.0015	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ODC1—colon cancer	0.0002	0.0015	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CHST5—colon cancer	0.0002	0.0015	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CHST5—colon cancer	0.0002	0.0015	CbGpPWpGaD
Diclofenamide—Body temperature increased—Irinotecan—colon cancer	0.000196	0.00699	CcSEcCtD
Diclofenamide—Feeling abnormal—Fluorouracil—colon cancer	0.000196	0.00698	CcSEcCtD
Diclofenamide—Drowsiness—Methotrexate—colon cancer	0.000194	0.00691	CcSEcCtD
Diclofenamide—Tremor—Capecitabine—colon cancer	0.000191	0.00679	CcSEcCtD
Diclofenamide—CA1—C-MYB transcription factor network—PTGS2—colon cancer	0.00019	0.00142	CbGpPWpGaD
Diclofenamide—Body temperature increased—Fluorouracil—colon cancer	0.000188	0.0067	CcSEcCtD
Diclofenamide—CA7—Metabolism—CHST5—colon cancer	0.000186	0.0014	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ODC1—colon cancer	0.000186	0.0014	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CHST5—colon cancer	0.000186	0.0014	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ODC1—colon cancer	0.000186	0.0014	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CA7—colon cancer	0.000184	0.00138	CbGpPWpGaD
Diclofenamide—Asthenia—Vincristine—colon cancer	0.000183	0.00651	CcSEcCtD
Diclofenamide—Leukopenia—Capecitabine—colon cancer	0.000182	0.00649	CcSEcCtD
Diclofenamide—Agranulocytosis—Methotrexate—colon cancer	0.000181	0.00645	CcSEcCtD
Diclofenamide—Asthenia—Irinotecan—colon cancer	0.000178	0.00634	CcSEcCtD
Diclofenamide—CA12—Metabolism—ODC1—colon cancer	0.000173	0.00129	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CHST5—colon cancer	0.000173	0.00129	CbGpPWpGaD
Diclofenamide—CA1—C-MYB transcription factor network—CCND1—colon cancer	0.000172	0.00129	CbGpPWpGaD
Diclofenamide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000169	0.00126	CbGpPWpGaD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000168	0.00126	CbGpPWpGaD
Diclofenamide—Dizziness—Vincristine—colon cancer	0.000168	0.006	CcSEcCtD
Diclofenamide—Pruritus—Fluorouracil—colon cancer	0.000168	0.00599	CcSEcCtD
Diclofenamide—Confusional state—Capecitabine—colon cancer	0.000167	0.00597	CcSEcCtD
Diclofenamide—CA1—C-MYB transcription factor network—CDKN1A—colon cancer	0.000166	0.00124	CbGpPWpGaD
Diclofenamide—Dizziness—Irinotecan—colon cancer	0.000164	0.00585	CcSEcCtD
Diclofenamide—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	0.000164	0.00123	CbGpPWpGaD
Diclofenamide—Thrombocytopenia—Capecitabine—colon cancer	0.000163	0.00579	CcSEcCtD
Diclofenamide—Tinnitus—Methotrexate—colon cancer	0.000162	0.00578	CcSEcCtD
Diclofenamide—Vomiting—Vincristine—colon cancer	0.000162	0.00577	CcSEcCtD
Diclofenamide—Rash—Vincristine—colon cancer	0.000161	0.00573	CcSEcCtD
Diclofenamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000161	0.0012	CbGpPWpGaD
Diclofenamide—Headache—Vincristine—colon cancer	0.00016	0.00569	CcSEcCtD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.00016	0.0012	CbGpPWpGaD
Diclofenamide—Anorexia—Capecitabine—colon cancer	0.000158	0.00564	CcSEcCtD
Diclofenamide—CA1—C-MYB transcription factor network—EP300—colon cancer	0.000158	0.00118	CbGpPWpGaD
Diclofenamide—Vomiting—Irinotecan—colon cancer	0.000158	0.00562	CcSEcCtD
Diclofenamide—Dizziness—Fluorouracil—colon cancer	0.000157	0.0056	CcSEcCtD
Diclofenamide—Rash—Irinotecan—colon cancer	0.000156	0.00558	CcSEcCtD
Diclofenamide—Headache—Irinotecan—colon cancer	0.000155	0.00554	CcSEcCtD
Diclofenamide—Nausea—Vincristine—colon cancer	0.000151	0.00539	CcSEcCtD
Diclofenamide—Vomiting—Fluorouracil—colon cancer	0.000151	0.00539	CcSEcCtD
Diclofenamide—Rash—Fluorouracil—colon cancer	0.00015	0.00534	CcSEcCtD
Diclofenamide—Paraesthesia—Capecitabine—colon cancer	0.000149	0.00531	CcSEcCtD
Diclofenamide—Headache—Fluorouracil—colon cancer	0.000149	0.00531	CcSEcCtD
Diclofenamide—CA1—C-MYB transcription factor network—NRAS—colon cancer	0.000148	0.00111	CbGpPWpGaD
Diclofenamide—Nausea—Irinotecan—colon cancer	0.000147	0.00525	CcSEcCtD
Diclofenamide—Dyspepsia—Capecitabine—colon cancer	0.000146	0.00521	CcSEcCtD
Diclofenamide—Decreased appetite—Capecitabine—colon cancer	0.000144	0.00515	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000143	0.00511	CcSEcCtD
Diclofenamide—Fatigue—Capecitabine—colon cancer	0.000143	0.0051	CcSEcCtD
Diclofenamide—Constipation—Capecitabine—colon cancer	0.000142	0.00506	CcSEcCtD
Diclofenamide—Nausea—Fluorouracil—colon cancer	0.000141	0.00503	CcSEcCtD
Diclofenamide—CA4—Metabolism—ODC1—colon cancer	0.000138	0.00103	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CHST5—colon cancer	0.000138	0.00103	CbGpPWpGaD
Diclofenamide—CA1—C-MYB transcription factor network—MYC—colon cancer	0.000138	0.00103	CbGpPWpGaD
Diclofenamide—Feeling abnormal—Capecitabine—colon cancer	0.000137	0.00488	CcSEcCtD
Diclofenamide—Leukopenia—Methotrexate—colon cancer	0.000136	0.00483	CcSEcCtD
Diclofenamide—CA2—Metabolism—CHST5—colon cancer	0.000132	0.00099	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ODC1—colon cancer	0.000132	0.00099	CbGpPWpGaD
Diclofenamide—Body temperature increased—Capecitabine—colon cancer	0.000131	0.00468	CcSEcCtD
Diclofenamide—CA1—C-MYB transcription factor network—KRAS—colon cancer	0.000127	0.000953	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CHST5—colon cancer	0.000127	0.000949	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ODC1—colon cancer	0.000127	0.000949	CbGpPWpGaD
Diclofenamide—Confusional state—Methotrexate—colon cancer	0.000125	0.00444	CcSEcCtD
Diclofenamide—Thrombocytopenia—Methotrexate—colon cancer	0.000121	0.00431	CcSEcCtD
Diclofenamide—Asthenia—Capecitabine—colon cancer	0.000119	0.00425	CcSEcCtD
Diclofenamide—Anorexia—Methotrexate—colon cancer	0.000118	0.0042	CcSEcCtD
Diclofenamide—Pruritus—Capecitabine—colon cancer	0.000117	0.00419	CcSEcCtD
Diclofenamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000112	0.000837	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CHST5—colon cancer	0.000111	0.000834	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ODC1—colon cancer	0.000111	0.000834	CbGpPWpGaD
Diclofenamide—Paraesthesia—Methotrexate—colon cancer	0.000111	0.00396	CcSEcCtD
Diclofenamide—Somnolence—Methotrexate—colon cancer	0.00011	0.00392	CcSEcCtD
Diclofenamide—Dizziness—Capecitabine—colon cancer	0.00011	0.00391	CcSEcCtD
Diclofenamide—Dyspepsia—Methotrexate—colon cancer	0.000109	0.00388	CcSEcCtD
Diclofenamide—CA1—C-MYB transcription factor network—HRAS—colon cancer	0.000108	0.00081	CbGpPWpGaD
Diclofenamide—Decreased appetite—Methotrexate—colon cancer	0.000107	0.00383	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000107	0.0038	CcSEcCtD
Diclofenamide—Fatigue—Methotrexate—colon cancer	0.000107	0.0038	CcSEcCtD
Diclofenamide—Vomiting—Capecitabine—colon cancer	0.000106	0.00376	CcSEcCtD
Diclofenamide—Rash—Capecitabine—colon cancer	0.000105	0.00373	CcSEcCtD
Diclofenamide—Headache—Capecitabine—colon cancer	0.000104	0.00371	CcSEcCtD
Diclofenamide—Feeling abnormal—Methotrexate—colon cancer	0.000102	0.00363	CcSEcCtD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—AKT1—colon cancer	0.000102	0.000763	CbGpPWpGaD
Diclofenamide—Nausea—Capecitabine—colon cancer	9.86e-05	0.00352	CcSEcCtD
Diclofenamide—Body temperature increased—Methotrexate—colon cancer	9.77e-05	0.00348	CcSEcCtD
Diclofenamide—Asthenia—Methotrexate—colon cancer	8.87e-05	0.00316	CcSEcCtD
Diclofenamide—Pruritus—Methotrexate—colon cancer	8.74e-05	0.00312	CcSEcCtD
Diclofenamide—Dizziness—Methotrexate—colon cancer	8.17e-05	0.00291	CcSEcCtD
Diclofenamide—Vomiting—Methotrexate—colon cancer	7.86e-05	0.0028	CcSEcCtD
Diclofenamide—Rash—Methotrexate—colon cancer	7.79e-05	0.00278	CcSEcCtD
Diclofenamide—Headache—Methotrexate—colon cancer	7.74e-05	0.00276	CcSEcCtD
Diclofenamide—Nausea—Methotrexate—colon cancer	7.34e-05	0.00262	CcSEcCtD
Diclofenamide—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	6.45e-05	0.000484	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—CDKN1A—colon cancer	5.84e-05	0.000438	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—EP300—colon cancer	5.56e-05	0.000416	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ABCB1—colon cancer	5.41e-05	0.000406	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—TYMS—colon cancer	5.32e-05	0.000399	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ABCB1—colon cancer	5.28e-05	0.000395	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ABCB1—colon cancer	5.28e-05	0.000395	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—VEGFA—colon cancer	5.26e-05	0.000394	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—TYMS—colon cancer	5.18e-05	0.000388	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—TYMS—colon cancer	5.18e-05	0.000388	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ABCB1—colon cancer	4.93e-05	0.000369	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ABCB1—colon cancer	4.93e-05	0.000369	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—TYMS—colon cancer	4.84e-05	0.000363	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—TYMS—colon cancer	4.84e-05	0.000363	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CA7—colon cancer	4.69e-05	0.000351	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ABCB1—colon cancer	4.56e-05	0.000342	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—TYMS—colon cancer	4.48e-05	0.000336	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—TP53—colon cancer	3.98e-05	0.000298	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PPARG—colon cancer	3.77e-05	0.000282	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PPARG—colon cancer	3.67e-05	0.000275	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PPARG—colon cancer	3.67e-05	0.000275	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ABCB1—colon cancer	3.64e-05	0.000273	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—TYMS—colon cancer	3.57e-05	0.000268	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ABCB1—colon cancer	3.49e-05	0.000262	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PPARG—colon cancer	3.43e-05	0.000257	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PPARG—colon cancer	3.43e-05	0.000257	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—TYMS—colon cancer	3.43e-05	0.000257	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ABCB1—colon cancer	3.35e-05	0.000251	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—TYMS—colon cancer	3.29e-05	0.000246	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PPARG—colon cancer	3.17e-05	0.000238	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTGS2—colon cancer	2.96e-05	0.000222	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ABCB1—colon cancer	2.94e-05	0.00022	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—TYMS—colon cancer	2.89e-05	0.000216	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTGS2—colon cancer	2.89e-05	0.000216	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTGS2—colon cancer	2.89e-05	0.000216	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CHST5—colon cancer	2.84e-05	0.000213	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ODC1—colon cancer	2.84e-05	0.000213	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTGS2—colon cancer	2.7e-05	0.000202	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTGS2—colon cancer	2.7e-05	0.000202	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PPARG—colon cancer	2.53e-05	0.00019	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTGS2—colon cancer	2.5e-05	0.000187	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—EP300—colon cancer	2.46e-05	0.000185	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPARG—colon cancer	2.43e-05	0.000182	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—EP300—colon cancer	2.4e-05	0.00018	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—EP300—colon cancer	2.4e-05	0.00018	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPARG—colon cancer	2.33e-05	0.000174	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—EP300—colon cancer	2.24e-05	0.000168	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—EP300—colon cancer	2.24e-05	0.000168	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—EP300—colon cancer	2.08e-05	0.000156	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPARG—colon cancer	2.05e-05	0.000153	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTGS2—colon cancer	1.99e-05	0.000149	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTGS2—colon cancer	1.91e-05	0.000143	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTGS2—colon cancer	1.83e-05	0.000137	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CA—colon cancer	1.82e-05	0.000137	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CA—colon cancer	1.78e-05	0.000133	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CA—colon cancer	1.78e-05	0.000133	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CA—colon cancer	1.66e-05	0.000124	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CA—colon cancer	1.66e-05	0.000124	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—EP300—colon cancer	1.66e-05	0.000124	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTGS2—colon cancer	1.61e-05	0.000121	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—EP300—colon cancer	1.59e-05	0.000119	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CA—colon cancer	1.54e-05	0.000115	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—EP300—colon cancer	1.52e-05	0.000114	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AKT1—colon cancer	1.49e-05	0.000112	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AKT1—colon cancer	1.45e-05	0.000109	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AKT1—colon cancer	1.45e-05	0.000109	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AKT1—colon cancer	1.35e-05	0.000102	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AKT1—colon cancer	1.35e-05	0.000102	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—EP300—colon cancer	1.34e-05	0.0001	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AKT1—colon cancer	1.26e-05	9.41e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CA—colon cancer	1.23e-05	9.18e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CA—colon cancer	1.17e-05	8.81e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.17e-05	8.79e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CA—colon cancer	1.13e-05	8.44e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AKT1—colon cancer	1e-05	7.5e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CA—colon cancer	9.9e-06	7.42e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AKT1—colon cancer	9.6e-06	7.19e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.22e-06	6.91e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AKT1—colon cancer	9.2e-06	6.9e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AKT1—colon cancer	8.09e-06	6.06e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.67e-06	5.75e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCB1—colon cancer	7.51e-06	5.63e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TYMS—colon cancer	7.37e-06	5.53e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.68e-06	4.25e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARG—colon cancer	5.22e-06	3.91e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGS2—colon cancer	4.11e-06	3.08e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—EP300—colon cancer	3.42e-06	2.56e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CA—colon cancer	2.53e-06	1.89e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKT1—colon cancer	2.06e-06	1.55e-05	CbGpPWpGaD
